Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by LCS.
Page 3: 1 2 3 4 5 6 7 8 9
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
---|---|---|---|---|---|
601 | 6 | 29 | 569 1973 FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE 41(7):378-417 GIBBELS E; SCHEID W; WIECK HH; KINZEL W THALIDOMIDE-NEUROPATHY IN LATE STAGE | 6 | 5 |
602 | 6 | 20 | 633 1976 TERATOLOGY 14(1):71-87 MCBRIDE WG STUDIES OF ETIOLOGY OF THALIDOMIDE DYSMORPHOGENESIS | 6 | 28 |
603 | 13 | 145 | 662 1977 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 32(3-4):241-248 HANAUSKEABEL H; GUNZLER V INHIBITION OF HUMAN PROLYL HYDROXYLASE AS COMMON BIOCHEMICAL DENOMINATOR OF NON-SEDATIVE EFFECTS OF THALIDOMIDE IN MAN | 6 | 8 |
604 | 5 | 20 | 746 1981 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 98(4):1029-1034 BRAUN AG; DAILEY JP THALIDOMIDE METABOLITE INHIBITS TUMOR-CELL ATTACHMENT TO CONCANAVALIN A COATED SURFACES | 6 | 16 |
605 | 4 | 18 | 759 1981 PATHOLOGIE BIOLOGIE 29(10):601-604 FAURE M; LEJEUNE JP; GAUCHERAND M; THIVOLET J PMN LEUKOCYTES CHEMOTAXIS - INHIBITION BY THALIDOMIDE | 6 | 9 |
606 | 0 | 0 | 782 1982 EEG-EMG-ZEITSCHRIFT FUR ELEKTROENZEPHALOGRAPHIE ELEKTROMYOGRAPHIE UND VERWANDTE GEBIETE 13(4):167-170 LUDOLPH A; MATZ DR ELECTRONEUROGRAPHIC STUDIES IN PATIENTS UNDER THALIDOMIDE THERAPY OF LUPUS ERYTHEMATODES DISCOIDES | 6 | 1 |
607 | 0 | 2 | 851 1984 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 8(2):196-196 ROGE J; TESTAS P THALIDOMIDE IN BEHCETS SYNDROME | 6 | 7 |
608 | 1 | 4 | 857 1984 LANCET 2(8394):98-99 NIELSEN H; BENNIKE T THALIDOMIDE ENHANCES DEFECTIVE MONOCYTE FUNCTION IN LEPROMATOUS LEPROSY | 6 | 8 |
609 | 11 | 35 | 918 1986 CLINICS IN PERINATOLOGY 13(3):555-573 NEWMAN CGH THE THALIDOMIDE SYNDROME - RISKS OF EXPOSURE AND SPECTRUM OF MALFORMATIONS | 6 | 19 |
610 | 5 | 10 | 924 1986 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 14(2):282-283 ARONSON IK; WEBER L; WEST D; BUYS C; REDER A; ANTEL J THALIDOMIDE AND LYMPHOCYTE FUNCTION | 6 | 6 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
611 | 12 | 32 | 941 1987 ARCHIVES OF TOXICOLOGY 60(5):376-381 STERZ H; NOTHDURFT H; LEXA P; OCKENFELS H TERATOLOGIC STUDIES ON THE HIMALAYAN RABBIT - NEW ASPECTS OF THALIDOMIDE-INDUCED TERATOGENESIS | 6 | 10 |
612 | 5 | 15 | 961 1988 ARCHIVES OF TOXICOLOGY 62(2-3):205-208 HEGER W; KLUG S; SCHMAHL HJ; NAU H; MERKER HJ; NEUBERT D EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES ON THE NON-HUMAN PRIMATE CALLITHRIX-JACCHUS .3. TERATOGENIC POTENCY OF THE EM-12 ENANTIOMERS | 6 | 13 |
613 | 0 | 3 | 964 1988 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 26(5):P623-P623 HAGUE D; SMITH RL ENIGMATIC PROPERTIES OF (+/-)-THALIDOMIDE - AN EXAMPLE OF A STABLE RACEMIC COMPOUND | 6 | 7 |
614 | 2 | 6 | 969 1988 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 56(4):625-625 SALAFIA A; KHARKAR RD THALIDOMIDE AND EXFOLIATIVE DERMATITIS | 6 | 6 |
615 | 22 | 219 | 984 1988 TERATOLOGY 38(3):241-251 BRENT RL; HOLMES LB CLINICAL AND BASIC SCIENCE LESSONS FROM THE THALIDOMIDE TRAGEDY - WHAT HAVE WE LEARNED ABOUT THE CAUSES OF LIMB DEFECTS | 6 | 36 |
616 | 2 | 4 | 1025 1990 MEDICAL JOURNAL OF AUSTRALIA 152(7):382-383 GEORGHIOU PR; KEMP RJ HIV-ASSOCIATED ESOPHAGEAL ULCERS TREATED WITH THALIDOMIDE | 6 | 9 |
617 | 10 | 38 | 1029 1990 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 10(4):281-294 HUANG PHT; MCBRIDE WG THALIDOMIDE INDUCED ALTERATION IN SECONDARY STRUCTURE OF RAT EMBRYONIC DNA INVIVO | 6 | 12 |
618 | 4 | 8 | 1038 1991 BRITISH MEDICAL JOURNAL 302(6792):1603-1604 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 6 | 7 |
619 | 4 | 6 | 1076 1992 TRANSPLANTATION PROCEEDINGS 24(6):2560-2561 ERIKSSON T; RIESBECK K; OSTRAAT O; EKBERG H; BJORKMAN S DRUG EXPOSURE AND FLOW-CYTOMETRY ANALYSES IN A THALIDOMIDE TREATMENT SCHEDULE THAT PROLONGS RAT CARDIAC GRAFT-SURVIVAL | 6 | 7 |
620 | 4 | 5 | 1089 1993 BONE MARROW TRANSPLANTATION 11(3):251-252 LOPEZ J; ULIBARRENA C; GARCIALARANA J; ODRIOZOLA J; DEOTEYZA JP; SASTRE JL; NAVARRO JL THALIDOMIDE AS THERAPY FOR INTESTINAL CHRONIC GVHD | 6 | 9 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
621 | 10 | 25 | 1146 1994 JOURNAL OF HEPATOLOGY 21(4):496-499 MCCORMICK PA; SCOTT F; EPSTEIN O; BURROUGHS AK; SCHEUER PJ; MCINTYRE N THALIDOMIDE AS THERAPY FOR PRIMARY BILIARY-CIRRHOSIS - A DOUBLE-BLIND PLACEBO-CONTROLLED PILOT-STUDY | 6 | 11 |
622 | 27 | 43 | 1158 1994 POSTGRADUATE MEDICAL JOURNAL 70(830):860-862 GARDNERMEDWIN JM; POWELL RJ THALIDOMIDE - THE WAY FORWARD | 6 | 9 |
623 | 9 | 18 | 1165 1995 ACTA NEUROPATHOLOGICA 89(5):415-419 SCHRODER JM; SELLHAUS B; WOHRMANN T; KOGEL B; ZWINGENBERGER K INHIBITORY EFFECTS OF THALIDOMIDE ON CELLULAR PROLIFERATION, ENDONEURIAL EDEMA AND MYELIN PHAGOCYTOSIS DURING EARLY WALLERIAN DEGENERATION | 6 | 9 |
624 | 8 | 10 | 1184 1995 CLINICAL BIOCHEMISTRY 28(4):467-470 LYON AW; DURAN G; RAISYS VA DETERMINATION OF THALIDOMIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - METHODOLOGICAL STRATEGY FOR CLINICAL-TRIALS | 6 | 7 |
625 | 6 | 6 | 1185 1995 CLINICAL CHEMISTRY 41(8):1199-1199 HUUPPONEN R; PYYKKO K STABILITY OF THALIDOMIDE IN HUMAN PLASMA | 6 | 8 |
626 | 4 | 31 | 1194 1995 FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 12(3-4):165-174 GEIST C; WOHRMANN T; SCHNEIDER J; ZWINGENBERGER K EFFECTS OF THALIDOMIDE ON THE LOCAL SHWARTZMAN REACTION IN MICE AND RABBITS | 6 | 8 |
627 | 3 | 13 | 1233 1996 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 123(6-7):375-377 Cherouati K; Claudy A; Souteyrand P; Cambazard F; Vaillant L; Moulin G; Crickx B; Morel P; Lamorelle A; Revuz J Thalidomide treatment of chronic erythema multiforme recurrent and continuous variants. A retrospective study of 26 patients. | 6 | 7 |
628 | 13 | 28 | 1252 1996 CHIRALITY 8(1):11-17 Reepmeyer JC Separation of R-and S-thalidomide by reversed-phase HPLC with beta-cyclodextrin in the mobile phase | 6 | 18 |
629 | 14 | 27 | 1314 1997 BIOCHEMICAL PHARMACOLOGY 53(10):1553-1557 Nicolai S; Sies H; Stahl W Stimulation of gap junctional intercellular communication by thalidomide and thalidomide analogs in human skin fibroblasts | 6 | 11 |
630 | 6 | 22 | 1324 1997 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 108(3):428-431 Hauschild A; Kroeger H; Mitchison NA; Ugrinovic S; Zwingenberger K Thalidomide therapy of established collagen-induced arthritis (CIA) not accompanied by an evident Th2 shift | 6 | 12 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
631 | 5 | 5 | 1326 1997 CLINICAL CHEMISTRY 43(6):1094-1095 Eriksson T; Bjorkman S Handling of blood samples for determination of thalidomide | 6 | 6 |
632 | 1 | 30 | 1457 1998 LANCET 351(9110):1197-1199 Dally A Thalidomide: was the tragedy preventable? | 6 | 16 |
633 | 18 | 29 | 1554 1999 INTERNATIONAL JOURNAL OF TOXICOLOGY 18(5):337-352 Teo SK; Trigg NJ; Shaw ME; Morgan JM; Thomas SD Subchronic toxicity of thalidomide in rodents after 13 weeks of oral administration | 6 | 6 |
634 | 27 | 52 | 1566 1999 JOURNAL OF INVESTIGATIVE DERMATOLOGY 113(5):720-724 Nasca MR; O'Toole EA; Palicharla P; West DP; Woodley DT Thalidomide increases human keratinocyte migration and proliferation | 6 | 14 |
635 | 14 | 40 | 1598 1999 REPRODUCTIVE TOXICOLOGY 13(6):547-554 Hansen JM; Carney EW; Harris C Differential alteration by thalidomide of the glutathione content of rat vs. rabbit conceptuses in vitro | 6 | 10 |
636 | 4 | 4 | 1624 2000 ARCHIVES OF DERMATOLOGY 136(12):1442-1443 Camisa C; Popovsky JL Effective treatment of oral erosive lichen planus with thalidomide | 6 | 11 |
637 | 15 | 33 | 1631 2000 BIOPHARMACEUTICS & DRUG DISPOSITION 21(1):33-40 Teo SK; Scheffler MR; Kook KA; Tracewell WG; Colburn WA; Stirling DI; Thomas SD Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women | 6 | 6 |
638 | 24 | 45 | 1688 2000 CANCER CHEMOTHERAPY AND PHARMACOLOGY 46(2):135-141 Kestell P; Zhao LL; Baguley BC; Palmer BD; Muller G; Paxton JW; Ching LM Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide | 6 | 20 |
639 | 8 | 8 | 1746 2000 JOURNAL OF INFECTIOUS DISEASES 182(2):639-639 Gori A; Rossi MC; Trabattoni D; Marchetti G; Fusi ML; Molteni C; Clerici M; Franzetti F Tumor necrosis factor-alpha increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection | 6 | 7 |
640 | 7 | 16 | 1776 2000 ONCOLOGY-NEW YORK 14(12):25-28 Hwu WJ New approaches in the treatment of metastatic melanoma: Thalidomide and temozolomide | 6 | 14 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
641 | 1 | 2 | 1780 2000 PALLIATIVE MEDICINE 14(1):77-78 Calder K; Bruera E Thalidomide for night sweats in patients with advanced cancer | 6 | 7 |
642 | 16 | 59 | 1783 2000 QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS 93(5):305-311 Davey PP; Ashrafian H New therapies for heart failure: is thalidomide the answer? | 6 | 9 |
643 | 9 | 27 | 1784 2000 SEMINARS IN HEMATOLOGY 37(1):1-4 Anderson KC Thalidomide: Therapeutic potential in hematologic malignancies | 6 | 8 |
644 | 10 | 37 | 1791 2000 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 20(1):35-47 Fort DJ; Stover EL; Bantle JA; Finch RA Evaluation of the developmental toxicity of thalidomide using Frog Embryo Teratogenesis Assay-Xenopus (FETAX): Biotransformation and detoxification | 6 | 8 |
645 | 115 | 191 | 1823 2001 BIODRUGS 15(10):681-703 Meierhofer C; Dunzendorfer S; Wiedermann CJ Theoretical basis for the activity of thalidomide | 6 | 12 |
646 | 32 | 67 | 1896 2001 CANCER 92(9):2364-2373 Tseng JE; Glisson BS; Khuri FR; Shin DM; Myers JN; El-Naggar AK; Roach JS; Ginsberg LE; Thall PF; Wang XM; Teddy S; Lawhorn KN; Zentgraf RE; Steinhaus GD; Pluda JM; Abbruzzese JL; Hong WK; Herbst RS Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck | 6 | 13 |
647 | 21 | 26 | 1958 2001 JOURNAL OF CLINICAL ONCOLOGY 19(16):3593-3595 Rajkumar SV; Kyle RA Thalidomide in the treatment of plasma cell malignancies | 6 | 7 |
648 | 13 | 18 | 1961 2001 JOURNAL OF CLINICAL PHARMACOLOGY 41(10):1091-1097 Aweeka F; Trapnell C; Chernoff M; Jayewardene A; Spritzler J; Bellibas SE; Lizak P; Jacobson J Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251 | 6 | 7 |
649 | 32 | 42 | 1978 2001 LUPUS 10(3):188-192 Karim MY; Ruiz-Irastorza G; Khamashta MA; Hughes GRV Update on therapy - thalidomide in the treatment of lupus | 6 | 13 |
650 | 3 | 14 | 2031 2002 ANNALS OF ONCOLOGY 13(7):1116-1119 Alexanian R; Weber D; Giralt S; Delasalle K Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy | 6 | 9 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
651 | 39 | 71 | 2041 2002 BIOLOGICAL & PHARMACEUTICAL BULLETIN 25(5):597-604 Marks MG; Shi JD; Fry MO; Xiao ZL; Trzyna M; Pokala V; Ihnat MA; Li PK Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation | 6 | 9 |
652 | 9 | 19 | 2130 2002 BONE MARROW TRANSPLANTATION 29(7):577-580 Ahmad I; Islam T; Chanan-Khan A; Hahn T; Wentling D; Becker JL; McCarthy PL; Alam AR Myeloma - Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT | 6 | 7 |
653 | 12 | 19 | 2211 2002 INVESTIGATIONAL NEW DRUGS 20(4):389-393 Minor DR; Monroe D; Damico LA; Meng G; Suryadevara U; Elias L A phase II study of thalidomide in advanced metastatic renal cell carcinoma | 6 | 9 |
654 | 41 | 67 | 2215 2002 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 6(2):160-174 Kumar S; Witzig TE; Rajkumar SV Thalidomide as an anti-cancer agent | 6 | 10 |
655 | 22 | 24 | 2223 2002 JOURNAL OF CLINICAL ONCOLOGY 20(11):2607-2609 Eisen T Thalidomide in solid malignancies | 6 | 12 |
656 | 21 | 29 | 2270 2002 NEUROLOGY 59(12):1872-1875 Chaudhry V; Cornblath DR; Corse A; Freimer M; Simmons-O'Brien E; Vogelsang G Thalidomide-induced neuropathy | 6 | 7 |
657 | 22 | 28 | 2428 2003 CANCER RESEARCH 63(3):593-599 Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins | 6 | 13 |
658 | 0 | 0 | 23 1961 BRITISH MEDICAL JOURNAL 2(525):1084-& HOWE P NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 5 | 6 |
659 | 2 | 14 | 42 1961 DISEASES OF THE NERVOUS SYSTEM 22(1):52-& NEUHAUS G; IBE K SURVIVAL FOLLOWING OVERDOSE OF THALIDOMIDE | 5 | 7 |
660 | 0 | 0 | 132 1962 LANCET 2(7247):151-& KAJII T THALIDOMIDE AND CONGENITAL DEFORMITIES | 5 | 10 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
661 | 0 | 0 | 156 1962 LANCET 2(7269):1332-& LUERS H FAILURE OF MUTAGENIC ACTION OF THALIDOMIDE IN DROSOPHILA | 5 | 8 |
662 | 15 | 28 | 184 1963 ACTA PHARMACOLOGICA ET TOXICOLOGICA 20(3):186-& LARSEN V TERATOGENIC EFFECTS OF THALIDOMIDE, IMIPRAMINE HCL AND IMIPRAMINE-N-OXIDE HCL ON WHITE DANISH RABBITS | 5 | 20 |
663 | 4 | 12 | 244 1963 LANCET 2(731):1068-& MILLER ZB INHIBITION OF TISSUE-CULTURE GROWTH BY A SOLUBLE THALIDOMIDE DERIVATIVE | 5 | 9 |
664 | 2 | 4 | 245 1963 MAYO CLINIC PROCEEDINGS 38(23):518-& WEIDMAN WH; YOUNG HH; ZOLLMAN PE EFFECT OF THALIDOMIDE ON UNBORN PUPPY | 5 | 3 |
665 | 2 | 4 | 260 1963 SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 93(44):1559-& FELISATI D; NODARI R EFFETS TOXIQUES ET TERATOGENIQUES DE LA THALIDOMIDE SUR LES FOETUS DE LAPIN | 5 | 7 |
666 | 2 | 10 | 271 1964 ARCHIVES OF OTOLARYNGOLOGY 80(2):136-140 DAVIGNON M; BARR B EAR ABNORMALITIES AND CRANIAL NERVE PALSIES IN THALIDOMIDE CHILDREN | 5 | 26 |
667 | 12 | 37 | 285 1964 JOURNAL OF PEDIATRICS 64(5):762-& BRENT RL DRUG TESTING IN ANIMALS FOR TERATOGENIC EFFECTS - THALIDOMIDE IN PREGNANT RAT | 5 | 39 |
668 | 1 | 8 | 300 1964 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 116(2):512-& KORANSKY W; ULLBERG S AUTORADIOGRAPHIC INVESTIGATIONS OF 14C-LABELLED THALIDOMIDE + GLUTETHIMIDE IN PREGNANT MICE | 5 | 15 |
669 | 12 | 26 | 337 1965 JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY 13:181-& DWORNIK JJ; MOORE KL SKELETAL MALFORMATIONS IN HOLTZMAN RAT EMBRYO FOLLOWING ADMINISTRATION OF THALIDOMIDE | 5 | 11 |
670 | 6 | 14 | 355 1965 TOXICOLOGY AND APPLIED PHARMACOLOGY 7(2):165-& DROBECK HP; COULSTON F; CORNELIU.D EFFECTS OF THALIDOMIDE ON FETAL DEVELOPMENT IN RABBITS AND ON ESTABLISHMENT OF PREGNANCY IN MONKEYS | 5 | 19 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
671 | 9 | 25 | 375 1966 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 8(6):761-& GORDON G MECHANISM OF THALIDOMIDE DEFORMITIES CORRELATED WITH PATHOGENIC EFFECTS OF PROLONGED DOSAGE IN ADULTS | 5 | 5 |
672 | 4 | 5 | 410 1966 VETERINARY RECORD 78(25):883-& JAFFE WP FAILURE OF THALIDOMIDE TO INFLUENCE HOMOGRAFT IMMUNITY IN CHICKENS | 5 | 5 |
673 | 4 | 16 | 486 1969 LANCET 1(7597):713-& [Anon] THALIDOMIDE NEUROPATHY | 5 | 0 |
674 | 4 | 37 | 525 1971 JOURNAL OF THE CHEMICAL SOCIETY B-PHYSICAL ORGANIC (6):1073-& ALLEN FH; TROTTER J CRYSTAL AND MOLECULAR STRUCTURE OF THALIDOMIDE, N-(ALPHA-GLUTARIMIDO)-PHTHALIMIDE | 5 | 29 |
675 | 6 | 21 | 574 1973 LANCET 2(7828):567-568 CRAWFORD CL TREATMENT OF ERYTHEMA-NODOSUM LEPROSUM WITH THALIDOMIDE | 5 | 5 |
676 | 1 | 3 | 598 1974 LANCET 1(7866):1111-1111 MCCREDIE J; MCLEOD JG THALIDOMIDE AND EMBRYONIC NEUROPATHY | 5 | 11 |
677 | 0 | 5 | 618 1976 ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY 102(7):425-427 TAKEMORI S; TANAKA Y; SUZUKI JI THALIDOMIDE ANOMALIES OF EAR | 5 | 12 |
678 | 0 | 0 | 670 1978 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 46(1):120-120 HASTINGS RC; MORALES MJ EFFECT OF THALIDOMIDE ON NEUTROPHIL FUNCTION | 5 | 5 |
679 | 2 | 15 | 718 1980 ARCHIV DER PHARMAZIE 313(6):481-487 FICKENTSCHER K; HALFMANN U; KOHLER F SYNTHESIS AND TERATOGENIC ACTIVITY OF SOME THALIDOMIDE ANALOGOUS INDANE-1,3-DIONES | 5 | 5 |
680 | 4 | 17 | 872 1985 ACTA NEUROPATHOLOGICA 65(3-4):285-292 SCHRODER JM; MATTHIESEN T EXPERIMENTAL THALIDOMIDE NEUROPATHY - THE MORPHOLOGICAL CORRELATE OF REDUCED CONDUCTION-VELOCITY | 5 | 7 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
681 | 2 | 3 | 876 1985 ARTHRITIS AND RHEUMATISM 28(7):836-836 MIYACHI Y A POSSIBLE MECHANISM OF ACTION OF THALIDOMIDE ON RHEUMATOID-ARTHRITIS | 5 | 5 |
682 | 6 | 13 | 902 1985 LEPROSY REVIEW 56(4):297-301 SHANNON EJ; TRUMAN RW; CHRISTY SA; BROWN LM; VADIEE R; HASTINGS RC EFFECT OF THALIDOMIDE ON INDUCTION OF ANTIBODY-SYNTHESIS IN MICE TO THE T-INDEPENDENT ANTIGEN, DNP-FICOLL | 5 | 6 |
683 | 17 | 30 | 906 1985 REVUE NEUROLOGIQUE 141(11):719-728 CHAPON F; LECHEVALIER B; DASILVA DC; RIVRAIN Y; DUPUY B; DESCHAMPS P THALIDOMIDE INDUCED NEUROPATHY | 5 | 8 |
684 | 8 | 15 | 916 1986 BRITISH JOURNAL OF DERMATOLOGY 115(6):677-680 MAURICE PDL; BARKLEY ASJ; ALLEN BR THE EFFECT OF THALIDOMIDE ON ARACHIDONIC-ACID METABOLISM IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES AND PLATELETS | 5 | 5 |
685 | 1 | 2 | 949 1987 PRENATAL DIAGNOSIS 7(4):295-298 GOLLOP TR; EIGIER A PRENATAL-DIAGNOSIS OF THALIDOMIDE SYNDROME | 5 | 6 |
686 | 11 | 14 | 1011 1990 EUROPEAN SURGICAL RESEARCH 22(6):336-339 EMRE S; SUMRANI N; HONG J BENEFICIAL EFFECT OF THALIDOMIDE AND CICLOSPORIN COMBINATION IN HETEROTOPIC CARDIAC TRANSPLANTATION IN RATS | 5 | 5 |
687 | 4 | 10 | 1039 1991 BRITISH MEDICAL JOURNAL 303(6800):470-470 WATERS MFR USE OF THALIDOMIDE IN LEPROSY | 5 | 5 |
688 | 0 | 0 | 1044 1991 INTERNATIONAL JOURNAL OF STD & AIDS 2(5):369-370 FULLER GN; JACOBS JM; GUILOFF RJ THALIDOMIDE, PERIPHERAL NEUROPATHY AND AIDS | 5 | 7 |
689 | 5 | 5 | 1073 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(10):735-735 CRAWFORD CL THALIDOMIDE NEUROPATHY | 5 | 6 |
690 | 7 | 10 | 1086 1993 ARCHIVES OF INTERNAL MEDICINE 153(4):534-534 VICENTE T; ORTEGA A; MUNOZ P; DIAZ MD; BOUZA E INVITRO ACTIVITY OF THALIDOMIDE AGAINST MYCOBACTERIUM-AVIUM COMPLEX | 5 | 6 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
691 | 0 | 0 | 1108 1993 PEDIATRIC DERMATOLOGY 10(3):283-285 MENNI S; IMONDI D; BRANCALEONE W; CROCI S RECURRENT GIANT APHTHOUS ULCERS IN A CHILD - PROTRACTED TREATMENT WITH THALIDOMIDE | 5 | 10 |
692 | 1 | 1 | 1132 1994 BRITISH MEDICAL JOURNAL 309(6956):741-741 KIDA M THALIDOMIDE MAY NOT BE A MUTAGEN | 5 | 7 |
693 | 9 | 34 | 1142 1994 IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 16(4):717-729 SHANNON EJ; HOWE RC; MCLEAN K; HASTINGS RC THALIDOMIDE DOES NOT PERTURB CD2, CD4, CD5, CD8, HLA-DR, OR HLA-A, HLA-B, HLA-C MOLECULES IN-VITRO ON THE MEMBRANES OF CELLS WITH IMMUNE POTENTIAL | 5 | 5 |
694 | 10 | 14 | 1197 1995 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 233(2):90-93 GUEXCROSIER Y; PITTET N; HERBORT CP THE EFFECT OF THALIDOMIDE AND SUPIDIMIDE ON ENDOTOXIN-INDUCED UVEITIS IN RATS | 5 | 6 |
695 | 10 | 14 | 1204 1995 JOURNAL OF LIQUID CHROMATOGRAPHY 18(2):297-309 DELON A; FAVRELIERE S; COUET W; COURTOIS PH; BOUQUET S RAPID AND SENSITIVE DETERMINATION OF THALIDOMIDE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY | 5 | 5 |
696 | 0 | 0 | 1209 1995 LANCET 346(8985):1289-1289 THOMPSON C THALIDOMIDE EFFECTIVE FOR AIDS-RELATED ORAL ULCERS | 5 | 10 |
697 | 9 | 12 | 1230 1996 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 53(4):368-& Weidle PJ Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus | 5 | 5 |
698 | 8 | 9 | 1257 1996 DERMATOLOGY 193(4):321-323 Bonnetblanc JM; Royer C; Bedane C Thalidomide and recurrent aphthous stomatitis: A follow-up study | 5 | 10 |
699 | 10 | 14 | 1292 1996 PEDIATRIC INFECTIOUS DISEASE JOURNAL 15(5):465-467 DeVincenzo JP; Burchet SK Prolonged thalidomide therapy for human immunodeficiency virus-associated recurrent severe esophageal and oral aphthous ulcers | 5 | 7 |
700 | 9 | 21 | 1342 1997 INFLAMMATION RESEARCH 46(10):392-397 Schneider J; Bruckmann W; Zwingenberger K Extravasation of leukocytes assessed by intravital microscopy: Effect of thalidomide | 5 | 13 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
701 | 0 | 0 | 1363 1997 JOURNAL OF THE NATIONAL CANCER INSTITUTE 89(20):1480-1481 Saphir A Jekyll and Hyde: A new license for thalidomide? | 5 | 7 |
702 | 4 | 24 | 1398 1998 ANTICANCER RESEARCH 18(6A):4409-4413 Browne WL; Wilson WR; Baguley BC; Ching LM Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid | 5 | 13 |
703 | 5 | 15 | 1407 1998 BIOLOGICAL & PHARMACEUTICAL BULLETIN 21(6):638-640 Ishikawa M; Kanno S; Takayanagi M; Takayanagi Y; Sasaki K Thalidomide promotes the release of tumor necrosis factor-alpha (TNF-alpha) and lethality by lipopolysaccharide in mice | 5 | 6 |
704 | 2 | 5 | 1428 1998 CLINICAL INFECTIOUS DISEASES 26(1):184-185 Gori A; Franzetti F; Marchetti G; Rossi C; Fusi ML; Ruzzante S; Clerici M Clinical and immunological improvement in a patient who received thalidomide treatment for refractory Mycobacterium avium complex infection | 5 | 7 |
705 | 10 | 55 | 1473 1998 PAIN 74(1):83-91 Sommer C; Marziniak M; Myers RR The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve | 5 | 54 |
706 | 8 | 24 | 1484 1999 AMERICAN JOURNAL OF PUBLIC HEALTH 89(1):98-101 Annas GJ; Elias S Thalidomide and the Titanic: Reconstructing the technology tragedies of the twentieth century | 5 | 7 |
707 | 6 | 11 | 1529 1999 CLINICAL NEUROPHYSIOLOGY 110(4):735-739 Sadoh DR; Hawk JLM; Panayiotopoulos CP F-chronodispersion in patients on thalidomide | 5 | 5 |
708 | 3 | 44 | 1533 1999 CURRENT EYE RESEARCH 19(6):483-490 Spraul CW; Kaven C; Kampmeier J; Lang GK; Lang GE Effect of thalidomide, octreotide, and prednisolone on the migration and proliferation of RPE cells in vitro | 5 | 9 |
709 | 2 | 5 | 1534 1999 DERMATOLOGY 199(2):195-195 Bez C; Lodi G; Sardella A; Della Volpe A; Carrassi A Oral lichenoid lesions after thalidomide treatment | 5 | 5 |
710 | 15 | 23 | 1535 1999 DRUG SAFETY 21(3):161-169 Lary JM; Daniel KL; Erickson JD; Roberts HE; Moore CA The return of thalidomide - Can birth defects be prevented? | 5 | 10 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
711 | 6 | 15 | 1565 1999 JOURNAL OF INFECTIOUS DISEASES 180(1):216-219 Meierhofer C; Dunzendorfer S; Wiederman CJ Protein kinase C-dependent effects on leukocyte migration of thalidomide | 5 | 10 |
712 | 5 | 14 | 1579 1999 MEDICAL HYPOTHESES 53(1):76-77 Sastry PSRK Inhibition of TNF-alpha synthesis with thalidomide for prevention of acute exacerbations and altering the natural history of multiple sclerosis | 5 | 7 |
713 | 4 | 13 | 1592 1999 ORGANIC PROCESS RESEARCH & DEVELOPMENT 3(2):139-140 Muller GW; Konnecke WE; Smith AM; Khetani VD A concise two-step synthesis of thalidomide | 5 | 12 |
714 | 15 | 35 | 1600 1999 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 12(6):305-311 Monastirli A; Georgiou S; Bolsen K; Pasmatzi E; Papapanagiotou A; Goerz G; Kalofoutis A; Merk HF; Tsambaos D Treatment of porphyria cutanea tarda with oral thalidomide | 5 | 6 |
715 | 84 | 136 | 1604 1999 TERATOLOGY 60(5):306-321 Miller MT; Stromland K Teratogen update: Thalidomide: A review, with a focus on ocular findings and new potential uses | 5 | 16 |
716 | 5 | 5 | 1608 2000 AIDS 14(12):1859-1861 Gori A; Rossi MC; Marchetti G; Trabattoni D; Molteni C; Cogliati M; Bandera A; Clerici M; Franzetti F Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease | 5 | 7 |
717 | 23 | 38 | 1622 2000 ANTI-CANCER DRUGS 11(10):787-791 Adlard JW Thalidomide in the treatment of cancer | 5 | 11 |
718 | 1 | 1 | 1686 2000 BRITISH JOURNAL OF HAEMATOLOGY 111(3):986-986 Myers B; Crouch D; Dolan G Thalidomide treatment in advanced refractory myeloma | 5 | 5 |
719 | 4 | 8 | 1718 2000 GASTROENTEROLOGY 119(2):596-596 Fishman SJ; Feins NR; D'Amato RJ; Folkman J Thalidomide therapy for Crohn's disease | 5 | 12 |
720 | 7 | 16 | 1758 2000 MAYO CLINIC PROCEEDINGS 75(8):842-844 Federman GL; Federman DG Recalcitrant pyoderma gangrenosum treated with thalidomide | 5 | 12 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
721 | 4 | 5 | 1763 2000 MUSCLE & NERVE 23(8):1301-1302 Rao DG; Kane NM; Oware A Thalidomide neuropathy: Role of F-wave monitoring | 5 | 5 |
722 | 3 | 15 | 1786 2000 SEMINARS IN HEMATOLOGY 37(1):15-21 Munshi NC; Desikan KR; Barlogie B Clinical experience with thalidomide in multiple myeloma: Phase II trial results in refractory disease and ongoing studies | 5 | 6 |
723 | 5 | 42 | 1789 2000 SEMINARS IN HEMATOLOGY 37(1):35-39 Alexanian R; Anderson KC; Barlogie B; Stirling DI; Thomas DA Thalidomide in hematologic malignancies: Future directions | 5 | 5 |
724 | 19 | 37 | 1797 2000 TOXICOLOGY AND APPLIED PHARMACOLOGY 165(3):237-244 Karrow NA; McCay JA; Brown RD; Musgrove DL; Pettit DA; Munson AE; Germolec DR; White KL Thalidomide stimulates splenic IgM antibody response and cytotoxic T lymphocyte activity and alters leukocyte subpopulation numbers in female B6C3F1 mice | 5 | 8 |
725 | 8 | 12 | 1803 2001 AMERICAN JOURNAL OF HEMATOLOGY 66(4):300-302 Fowler R; Imrie K Thalidomide-associated hepatitis: A case report | 5 | 6 |
726 | 11 | 12 | 1807 2001 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 128(5):611-613 Estines O; Revuz J; Wolkenstein P; Bressieux JM; Roujeau JC; Cosnes A Sarcoidosis: thalidomide treatment in ten patients | 5 | 6 |
727 | 3 | 10 | 1902 2001 CHILDS NERVOUS SYSTEM 17(6):370-372 Schoeman JF; Ravenscroft A; Hartzenberg HB Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess | 5 | 5 |
728 | 3 | 3 | 1905 2001 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 19(3):360-361 Scoville CD Pilot study using the combination of methotrexate and thalidomide in the treatment of rheumatoid arthritis | 5 | 5 |
729 | 13 | 23 | 1949 2001 INTERNATIONAL IMMUNOPHARMACOLOGY 1(1):49-61 Rowland TL; McHugh SM; Deighton J; Ewan PW; Dearman RJ; Kimber I Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B | 5 | 8 |
730 | 3 | 3 | 1998 2001 PRESSE MEDICALE 30(20):1008-1009 Pouaha J; Martin S; Trechot P; Truchetet F; Barbaud A; Schmutz JL Thalidomide and thrombosis: three cases | 5 | 5 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
731 | 14 | 41 | 2002 2001 RHEUMATOLOGY 40(8):933-938 Kari JA; Shah V; Dillon MJ Behcet's disease in UK children: clinical features and treatment including thalidomide | 5 | 14 |
732 | 7 | 21 | 2007 2001 SEMINARS IN ONCOLOGY 28(6):583-587 Kyle RA; Rajkumar SV Therapeutic application of thalidomide in multiple myeloma | 5 | 9 |
733 | 1 | 3 | 2029 2002 ANNALS OF INTERNAL MEDICINE 136(9):711-711 Escudier B; Lassau N; Leborgne S; Angevin E; Laplanche A Thalidomide and venous thrombosis | 5 | 8 |
734 | 20 | 42 | 2044 2002 BIOMEDICINE & PHARMACOTHERAPY 56(1):13-19 Sampaio EP; Hernandez MO; Carvalho DS; Sarno EN Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M-leprae-induced TNF alpha production in vitro | 5 | 6 |
735 | 56 | 93 | 2047 2002 BIOMEDICINE & PHARMACOTHERAPY 56(3):115-128 Richardson P; Hideshima T; Anderson K Thalidomide in multiple myeloma | 5 | 6 |
736 | 32 | 45 | 2048 2002 BIOMEDICINE & PHARMACOTHERAPY 56(4):194-199 Ng SSW; Brown M; Figg WD Thalidomide, an antiangiogenic agent with clinical activity in cancer | 5 | 6 |
737 | 13 | 33 | 2147 2002 CANCER 95(4):758-765 Daliani DD; Papandreou CN; Thall PF; Wang XM; Perez C; Oliva R; Pagliaro L; Amato R A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma | 5 | 10 |
738 | 33 | 53 | 2170 2002 CURRENT OPINION IN ONCOLOGY 14(6):635-640 Raje N; Anderson KC Thalidomide and immunomodulatory drugs as cancer therapy | 5 | 10 |
739 | 13 | 15 | 2232 2002 JOURNAL OF INFECTIOUS DISEASES 185(9):1359-1363 Wohl DA; Aweeka FT; Schmitz J; Pomerantz R; Cherng DW; Spritzler J; Fox L; Simpson D; Bell D; Holohan MK; Thomas S; Robinson W; Kaplan G; Teppler H; Natl Inst Allergy Infect Dis AIDS Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267 | 5 | 5 |
740 | 5 | 31 | 2287 2002 SEMINARS IN ONCOLOGY 29(6):34-38 Durie BGM Low-dose thalidomide in myeloma: Efficacy and biologic significance | 5 | 7 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
741 | 15 | 47 | 2338 2003 BLOOD 101(7):2534-2541 Mesa RA; Steensma DP; Pardanani A; Li CY; Elliott M; Kaufmann SH; Wiseman G; Gray LA; Schroeder GE; Reeder T; Zeldis JB; Tefferi A A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia | 5 | 8 |
742 | 30 | 38 | 2434 2003 CLINICAL CANCER RESEARCH 9(5):1680-1688 Lu J; Palmer BD; Kestell P; Browett P; Baguley BC; Muller G; Ching LM Thalidomide metabolites in mice and patients with multiple myeloma | 5 | 6 |
743 | 1 | 2 | 5 1960 AMERICAN JOURNAL OF PSYCHIATRY 116(11):1030-1031 COHEN S SLEEP REGULATION WITH THALIDOMIDE | 4 | 9 |
744 | 0 | 1 | 17 1961 BRITISH MEDICAL JOURNAL 2(NOV11):1287-& SIMPSON JA NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 4 | 7 |
745 | 0 | 0 | 25 1961 BRITISH MEDICAL JOURNAL 2(526):1151-& POWELLTUCK GA NEUROPATHY AFTER THALIDOMIDE DISTAVAL | 4 | 5 |
746 | 0 | 0 | 27 1961 BRITISH MEDICAL JOURNAL 2(526):1223-& MEADE BW; ROSALKI SB NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 4 | 8 |
747 | 0 | 0 | 141 1962 LANCET 2(7252):400-& TOMS DA; APPLEBEY M; HUNTER TAA; WOOLLAM DHM; ASHLEY DJB THALIDOMIDE AND CONGENITAL ABNORMALITIES | 4 | 6 |
748 | 23 | 44 | 183 1963 ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA 59(4):491-& BACH A; BICHEL J; HEJGAARD JJ STUDIES ON POSSIBLE ANTI-NEOPLASTIC EFFECT OF THALIDOMIDE | 4 | 9 |
749 | 7 | 9 | 204 1963 CANADIAN MEDICAL ASSOCIATION JOURNAL 88(19):959-& MARTIN JK; RATHBUN JC HABILITATION OF PATIENTS WITH CONGENITAL MALFORMATIONS ASSOCIATED WITH THALIDOMIDE - PEDIATRIC ASPECTS | 4 | 4 |
750 | 0 | 5 | 234 1963 LANCET 1(728):725-& VILLA L; ERIDANI S CYTOLOGICAL EFFECTS OF THALIDOMIDE | 4 | 7 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
751 | 4 | 10 | 239 1963 LANCET 1(729):1374-& NARROD SA; KING CTG METABOLIC STUDIES WITH THALIDOMIDE | 4 | 9 |
752 | 1 | 1 | 292 1964 NATURE 201(492):940-& GIACOMELLO G; QUAGLIA G; MALATEST.P ACTION OF THALIDOMIDE ON RADICAL MERISTEMS OF ALLIUM CEPA | 4 | 9 |
753 | 0 | 3 | 302 1964 SCIENCE 144(362):1583-& DIPAOLO JA; WENNER CE THALIDOMIDE - EFFECTS ON EHRLICH ASCITES TUMOR CELLS IN VITRO | 4 | 9 |
754 | 1 | 10 | 305 1965 ACTA MEDICA SCANDINAVICA 177(6):783-& JENSEN MK CHROMOSOME ABERRATIONS IN HUMAN CELLS INDUCED BY THALIDOMIDE IN VITRO - PRELIMINARY REPORT | 4 | 12 |
755 | 0 | 0 | 380 1966 FEDERATION PROCEEDINGS 25(2P1):532-& MORI A; NYHAN WL; ASHIDA H METABOLISM OF THALIDOMIDE IN PREGNANT RATS | 4 | 5 |
756 | 0 | 0 | 460 1968 FEDERATION PROCEEDINGS 27(2):494-& OGILVIE JW; KANTOR FS EFFECT OF THALIDOMIDE ON IMMUNE RESPONSE | 4 | 4 |
757 | 4 | 12 | 484 1969 FOLIA PRIMATOLOGICA 10(3):195-& BARROW MV; STEFFEK AJ; KING CTG THALIDOMIDE SYNDROME IN RHESUS MONKEYS (MACACA MULATTA) | 4 | 9 |
758 | 1 | 14 | 504 1970 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 171(1):109-& BAKAY B; NYHAN WL EFFECTS OF THALIDOMIDE AND CHLORCYCLIZINE ON BIOSYNTHESIS OF NUCLEIC ACIDS AND PROTEINS IN FETAL AND MATERNAL TISSUES OF RAT | 4 | 5 |
759 | 2 | 13 | 507 1970 LANCET 1(7641):275-& PEMBREY ME; CLARKE CA NORMAL CHILD AFTER MATERNAL THALIDOMIDE INGESTION IN CRITICAL PERIOD OF PREGNANCY | 4 | 8 |
760 | 9 | 54 | 514 1971 ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE 194(1):39-& LOCKER D; SUPERSTI.E; SULMAN FG MECHANISM OF PUSH AND PULL PRINCIPLE .8. ENDOCRINE EFFECTS OF THALIDOMIDE AND ITS ANALOGUES | 4 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
761 | 2 | 8 | 630 1976 PHARMAZIE 31(7):492-493 OCKENFELS H; KOHLER F; MEISE W TERATOGENIC EFFECT AND STEREOSPECIFICITY OF A THALIDOMIDE METABOLITE | 4 | 9 |
762 | 0 | 7 | 636 1977 ACTA ORTHOPAEDICA SCANDINAVICA 48(3):273-276 EDWARDS DH; NICHOLS PJR SPINAL ABNORMALITIES IN THALIDOMIDE EMBRYOPATHY | 4 | 6 |
763 | 5 | 16 | 642 1977 BRITISH JOURNAL OF SURGERY 64(3):203-204 SHAND JEG; BREMNER DN AGENESIS OF VERMIFORM APPENDIX IN A THALIDOMIDE CHILD | 4 | 9 |
764 | 7 | 24 | 648 1977 JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY 41(OCT):125-135 BAZZOLI AS; MANSON J; SCOTT WJ; WILSON JG EFFECTS OF THALIDOMIDE AND 2 ANALOGS ON REGENERATING FORELIMB OF NEWT | 4 | 17 |
765 | 0 | 0 | 768 1981 TERATOLOGY 23(2):A65-A65 THEISEN CT; MCGREGOR EE FURTHER OBSERVATIONS ON THE DEVELOPMENT OF THALIDOMIDE INDUCED LIMB DEFORMITIES | 4 | 7 |
766 | 0 | 0 | 790 1982 TERATOLOGY 25(2):A47-A47 HELM FC; FRANKUS E CHEMICAL-STRUCTURE AND TERATOGENIC ACTIVITY OF THALIDOMIDE-RELATED COMPOUNDS | 4 | 4 |
767 | 7 | 12 | 824 1983 HAUTARZT 34(9):435-436 KNOP J; MACHER E THALIDOMIDE IN THE TREATMENT OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS | 4 | 4 |
768 | 2 | 4 | 831 1983 PRESSE MEDICALE 12(47):3007-3007 PRIGENT F; OUAZZANI W SARCOIDOSIS OF THE SKIN - TREATMENT WITH THALIDOMIDE | 4 | 4 |
769 | 21 | 38 | 832 1983 SEMAINE DES HOPITAUX 59(45):3101-3104 BELAUBE P; GARCIN G; MARCHAND JP; PRIVAT Y SHOULD THALIDOMIDE BE REHABILITATED | 4 | 7 |
770 | 0 | 0 | 840 1984 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 111(3):285-286 SCHNITZLER L THALIDOMIDE IN HAILEY-HAILEY DISEASE - GOOD BUT PALLIATIVE RESULTS | 4 | 11 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
771 | 9 | 144 | 856 1984 JOURNAL OF THEORETICAL BIOLOGY 110(3):461-486 SHULL GE DIFFERENTIAL INHIBITION OF PROTEIN-SYNTHESIS - A POSSIBLE BIOCHEMICAL-MECHANISM OF THALIDOMIDE TERATOGENESIS | 4 | 6 |
772 | 5 | 14 | 860 1984 MUSCLE & NERVE 7(5):362-368 SCHWAB BW; AREZZO JC; PALDINO AM; FLOHE L; MATTHIESSEN T; SPENCER PS RABBIT SURAL NERVE RESPONSES TO CHRONIC TREATMENT WITH THALIDOMIDE AND SUPIDIMIDE | 4 | 6 |
773 | 6 | 14 | 910 1986 ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION C-IMMUNOLOGY 94(6):233-237 NIELSEN H; VALERIUS NH THALIDOMIDE ENHANCES SUPEROXIDE ANION RELEASE FROM HUMAN POLYMORPHONUCLEAR AND MONONUCLEAR LEUKOCYTES | 4 | 7 |
774 | 8 | 28 | 922 1986 FOOD AND DRUG LAW JOURNAL 41(4):458-466 SHERMAN M; STRAUSS S THALIDOMIDE - A 25-YEAR PERSPECTIVE | 4 | 14 |
775 | 26 | 64 | 999 1989 MEDICAL HYPOTHESES 30(2):105-109 GUNZLER V THALIDOMIDE - A THERAPY FOR THE IMMUNOLOGICAL CONSEQUENCES OF HIV INFECTION | 4 | 6 |
776 | 11 | 33 | 1082 1993 ACTA OPHTHALMOLOGICA 71(2):238-245 STROMLAND K; MILLER MT THALIDOMIDE EMBRYOPATHY - REVISITED 27 YEARS LATER | 4 | 12 |
777 | 11 | 35 | 1106 1993 MOLECULAR AND CELLULAR BIOCHEMISTRY 129(2):195-200 WEGLICKI WB; STAFFORD RE; DICKENS BF; MAK IT; CASSIDY MM; PHILLIPS TM INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA BY THALIDOMIDE IN MAGNESIUM-DEFICIENCY | 4 | 9 |
778 | 4 | 10 | 1119 1994 ARCHIVES OF TOXICOLOGY 68(3):203-205 KLUG S; FELIES A; STURJE H; NOGUEIRA AC; NEUBERT R; FRANKUS E EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES IN THE NONHUMAN PRIMATE CALLITHRIX-JACCHUS .5. LACK OF TERATOGENIC EFFECTS OF PHTHALIMIDOPHTHALIMIDE | 4 | 7 |
779 | 5 | 5 | 1127 1994 BRITISH MEDICAL JOURNAL 308(6941):1437-1438 CRAWFORD CL SAFETY OF THALIDOMIDE | 4 | 4 |
780 | 3 | 5 | 1133 1994 BRITISH MEDICAL JOURNAL 309(6966):1442-1442 TENCONI R; CLEMENTI M; NOTARI L; VASCO VRLO AMNIOTIC BAND SEQUENCE IN CHILD OF THALIDOMIDE VICTIM | 4 | 6 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
781 | 0 | 1 | 1149 1994 LANCET 343(8900):795-796 CUTLER J THALIDOMIDE REVISITED | 4 | 5 |
782 | 3 | 5 | 1150 1994 LANCET 343(8904):1041-1041 JONES GRN THALIDOMIDE - 35 YEARS ON AND STILL DEFORMING | 4 | 5 |
783 | 3 | 5 | 1151 1994 LANCET 344(8916):196-197 TEIXEIRA F; HOJYO MT; ARENAS R; VEGA ME; CORTES R; ORTIZ A; DOMINGUEZ L THALIDOMIDE - CAN IT CONTINUE TO BE USED | 4 | 4 |
784 | 22 | 45 | 1162 1994 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 40(5):535-542 ARALACHAVES M; VILANOVA M; RIBEIRO A; PINTO J IMMUNOSTIMULATORY EFFECT OF THALIDOMIDE IN NORMAL C57BL/6 MICE IS COMPATIBLE WITH STIMULATION OF A HIGHLY CONNECTED CENTRAL IMMUNE-SYSTEM .1. | 4 | 6 |
785 | 11 | 26 | 1163 1994 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 40(5):543-548 VILANOVA M; RIBEIRO A; CARNEIRO J; ARALACHAVES M THE EFFECTS OF THALIDOMIDE TREATMENT ON AUTOIMMUNE-PRONE NZB AND MRL MICE ARE CONSISTENT WITH STIMULATION OF THE CENTRAL IMMUNE-SYSTEM .2. | 4 | 5 |
786 | 6 | 40 | 1198 1995 HAUTARZT 46(8):553-560 DALLAFIOR S; PUGIN P; CERNY T; BETTICHER D; SAURAT JH; HAUSER C A CASE OF CUTANEOUS LANGERHANS CELL GRANULOMATOSIS SUCCESSFULLY TREATED WITH 2-CHLORODEOXYADENOSINE AND THALIDOMIDE | 4 | 9 |
787 | 2 | 4 | 1232 1996 AMERICAN JOURNAL OF OPHTHALMOLOGY 122(4):594-595 Ip M; Gorin MB Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide | 4 | 13 |
788 | 2 | 5 | 1283 1996 LANCET 347(9006):974-974 Verberkmoes A; Boer K; Wertheim PME; Bronkhorst CM; Lange JMA Thalidomide for genital ulcer in HIV-positive woman | 4 | 9 |
789 | 14 | 21 | 1322 1997 CHEMTECH 27(1):21-25 Muller GW Thalidomide: From tragedy to new drug discovery | 4 | 9 |
790 | 3 | 9 | 1323 1997 CLINICAL AND EXPERIMENTAL DERMATOLOGY 22(6):297-299 Darvay A; Basarab T; Russell-Jones R Thalidomide-induced toxic pustuloderma | 4 | 8 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
791 | 6 | 35 | 1341 1997 IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 19(3):313-326 Aseffa A; Dietrich MA; Shannon EJ Effect of thalidomide on apoptosis of lymphocytes and neutrophils | 4 | 5 |
792 | 5 | 19 | 1397 1998 ANNALS OF INTERNAL MEDICINE 128(6):494-495 Ehrlich GE Behcet disease and the emergence of thalidomide | 4 | 19 |
793 | 6 | 10 | 1427 1998 CLINICAL AND EXPERIMENTAL DERMATOLOGY 23(5):233-235 Herranz P; Pizarro A; de Lucas R; Arribas JR; Garcia-Tobaruela A; Pena JM; Casado M Treatment of AIDS-associated prurigo nodularis with thalidomide | 4 | 5 |
794 | 9 | 10 | 1431 1998 DRUG SAFETY 19(5):339-341 Smithells D Does thalidomide cause second generation birth defects? | 4 | 4 |
795 | 18 | 33 | 1477 1998 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 48(4):397-402 Zhu J; Deng GM; Diab A; Zwingenberger K; Bakhiet M; Link H Thalidomide prolongs experimental autoimmune neuritis in Lewis rats | 4 | 10 |
796 | 4 | 10 | 1528 1999 CLINICAL INFECTIOUS DISEASES 28(4):892-894 Ramirez-Amador VA; Esquivel-Pedraza L; Ponce-de-Leon S; Reyes-Teran G; Gonzalez-Guevara M; Ponce-de-Leon S; Sierra-Madero JG Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: A double-blind placebo-controlled clinical trial | 4 | 5 |
797 | 9 | 33 | 1546 1999 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 237(12):952-961 Joussen AM; Germann T; Kirchhof B Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency | 4 | 8 |
798 | 4 | 24 | 1553 1999 INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 80(1):11-16 Arrieta O; Ortiz-Reyes A; Rembao D; Calvillo M; Rivera E; Sotelo J Protective effect of pentoxifylline plus thalidomide against septic shock in mice | 4 | 8 |
799 | 13 | 49 | 1694 2000 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 121(3):472-479 Guckian M; Dransfield I; Hay P; Dalgleish AG Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro | 4 | 6 |
800 | 44 | 51 | 1733 2000 JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 6(1):19-26 Lenardo TM; Calabrese LH The role of thalidomide in the treatment of rheumatic disease | 4 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
801 | 3 | 13 | 1757 2000 LIFE SCIENCES 67(4):457-461 Thiele A; Thormann M; Hofmann HJ; Naumann WW; Eger K; Hauschildt S A possible role of N-cadherin in thalidomide teratogenicity | 4 | 6 |
802 | 8 | 38 | 1779 2000 PAIN 88(3):267-275 George A; Marziniak M; Schafers M; Toyka KV; Sommer C Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin | 4 | 20 |
803 | 8 | 25 | 1796 2000 TETRAHEDRON LETTERS 41(37):7151-7155 Luzzio FA; Thomas EM; Figg WD Thalidomide metabolites and analogs. Part 2: Cyclic derivatives of 2-N-phthalimido-2S,3S (3-hydroxy) ornithine | 4 | 6 |
804 | 3 | 7 | 1806 2001 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 128(2):148-149 Esteve E; Legac E Deep vein thrombosis and pulmonary embolism in a patient with aphtosis treated with thalidomide | 4 | 4 |
805 | 22 | 30 | 1809 2001 ANNALS OF ONCOLOGY 12(7):885-886 Thomas DA; Kantarjian HM The revitalization of thalidomide | 4 | 5 |
806 | 9 | 12 | 1884 2001 BRITISH JOURNAL OF DERMATOLOGY 144(2):227-228 Allen BR Thalidomide | 4 | 4 |
807 | 4 | 4 | 1886 2001 BRITISH JOURNAL OF DERMATOLOGY 144(6):1292-1293 Passeron T; Lacour JP; Murr D; Ortonne JP Thalidomide-induced amenorrhoea: two cases | 4 | 4 |
808 | 10 | 51 | 1899 2001 CANCER LETTERS 163(2):191-200 Myoung H; Hong SD; Kim YY; Hong SP; Kim MJ Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma | 4 | 10 |
809 | 100 | 115 | 1913 2001 DERMATOLOGIC CLINICS 19(1):87-+ Radomsky CL; Levine N Thalidomide | 4 | 8 |
810 | 47 | 67 | 1920 2001 DRUGS 61(6):777-787 Bousvaros A; Mueller B Thalidomide in gastrointestinal disorders | 4 | 8 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
811 | 32 | 52 | 2014 2001 TOXICOLOGICAL SCIENCES 59(1):160-168 Teo SK; Evans MG; Brockman MJ; Ehrhart J; Morgan JM; Stirling DI; Thomas SD Safety profile of thalidomide after 53 weeks of oral administration in beagle dogs | 4 | 4 |
812 | 21 | 36 | 2019 2002 ALIMENTARY PHARMACOLOGY & THERAPEUTICS 16(6):1117-1124 Sabate JM; Villarejo J; Lemann M; Bonnet J; Allez M; Modigliani R An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease | 4 | 14 |
813 | 15 | 29 | 2156 2002 CHEST 122(1):227-232 Baughman RP; Judson MA; Teirstein AS; Moller DR; Lower EE Thalidomide for chronic sarcoidosis | 4 | 24 |
814 | 12 | 49 | 2165 2002 CLINICAL IMMUNOLOGY 102(3):225-236 Oliver SJ; Kikuchi T; Krueger JG; Kaplan G Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement | 4 | 7 |
815 | 110 | 164 | 2176 2002 DRUGS & AGING 19(2):85-100 Zhou SF; Kestell P; Tingle MD; Paxton JW Thalidomide in cancer treatment - A potential role in the elderly? | 4 | 5 |
816 | 11 | 22 | 2204 2002 INTERNATIONAL IMMUNOPHARMACOLOGY 2(8):1143-1153 Shannon EJ; Sandoval FG Thalidomide can costimulate or suppress CD4(+) cells' ability to incorporate [H-3]-thymidine-dependence on the primary stimulant | 4 | 4 |
817 | 4 | 5 | 2222 2002 JOURNAL OF CLINICAL ONCOLOGY 20(8):2212-2212 Cany L; Fitoussi O; Boiron JM; Marit G Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma | 4 | 4 |
818 | 7 | 20 | 2240 2002 JOURNAL OF PEDIATRICS 140(1):125-127 Lehman TJA; Striegel KH; Onel KB Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis | 4 | 7 |
819 | 7 | 29 | 2259 2002 LEUKEMIA & LYMPHOMA 43(9):1777-1782 Coleman M; Leonard J; Lyons L; Pekle K; Nahum K; Pearse R; Niesvizky R; Michaeli J BLYD (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenstrom's macroglobulinemia | 4 | 6 |
820 | 7 | 17 | 2266 2002 MEDICAL ONCOLOGY 19(2):79-86 Merup M; Kutti J; Birgergard G; Mauritzson N; Bjorkholm M; Markevarn B; Malm C; Westin J; Palmblad J; Samuelsson J; Swedish Natl Study Grp Chronic Mye Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia | 4 | 5 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
821 | 4 | 17 | 2275 2002 ONCOLOGY-NEW YORK 16(4):23-26 Govindarajan R Irinoteean/Thalidomide in metastatic colorectal cancer | 4 | 5 |
822 | 7 | 24 | 2279 2002 PHARMACEUTICAL RESEARCH 19(1):13-19 Goosen C; Laing TJ; du Plessis J; Goosen TC; Flynn GL Physicochemical characterization and solubility analysis of thalidomide and its N-alkyl analogs | 4 | 4 |
823 | 19 | 40 | 2418 2003 BRITISH JOURNAL OF HAEMATOLOGY 122(4):607-616 Kropff MH; Lang N; Bisping G; Domine N; Innig G; Hentrich M; Mitterer M; Sudhoff T; Fenk R; Straka C; Heinecke A; Koch OM; Ostermann H; Berdel WE; Kienast J Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma | 4 | 8 |
824 | 16 | 25 | 2438 2003 CLINICAL LYMPHOMA 3(4):241-246 Seldin DC; Choufani EB; Dember LM; Wiesman JF; Berk JL; Falk RH; O'Hara C; Fennessey S; Finn KT; Wright DG; Skinner M; Sanchorawala V Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis | 4 | 8 |
825 | 0 | 0 | 36 1961 BRITISH MEDICAL JOURNAL 2(526):1499-& HAYMAN DJ WITHDRAWAL OF THALIDOMIDE (DISTAVAL) | 3 | 6 |
826 | 0 | 0 | 48 1961 MEDICAL JOURNAL OF AUSTRALIA 2(26):1030-& MCBRIDE WG CONGENITAL ABNORMALITIES AND THALIDOMIDE | 3 | 4 |
827 | 3 | 6 | 69 1962 BRITISH MEDICAL JOURNAL (5305):646-& WARD SP THALIDOMIDE AND CONGENITAL ABNORMALITIES | 3 | 3 |
828 | 13 | 23 | 106 1962 JOURNAL OF PEDIATRICS 61(1):153-& BLATTNER RJ DRUGS IN PREGNANCY - THALIDOMIDE | 3 | 3 |
829 | 4 | 4 | 108 1962 JOURNAL OF PEDIATRICS 61(2):318-& BLATTNER RJ THALIDOMIDE STUDIES IN EXPERIMENTAL ANIMALS | 3 | 5 |
830 | 0 | 0 | 147 1962 LANCET 2(7260):836-& OWEN R; SMITH A COR TRILOCULARE AND THALIDOMIDE | 3 | 5 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
831 | 7 | 25 | 174 1962 PRESSE MEDICALE 70(44):2053-& FARIZON F; MASBERNARD A EMBRYOPATHIE A LA THALIDOMIDE | 3 | 4 |
832 | 1 | 5 | 201 1963 CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE 41(7):1722-& MENARD M; ERICHOMO.L; LABROOY M; CHUBB FL QUELQUES METABOLITES POSSIBLES DE LA THALIDOMIDE | 3 | 8 |
833 | 0 | 10 | 206 1963 CANADIAN MEDICAL ASSOCIATION JOURNAL 88(19):964-& HALL JE HABILITATION OF PATIENTS WITH CONGENITAL MALFORMATIONS ASSOCIATED WITH THALIDOMIDE - SURGERY OF LIMB DEFECTS | 3 | 3 |
834 | 0 | 2 | 207 1963 CANADIAN MEDICAL ASSOCIATION JOURNAL 88(19):973-& GILPIN RE HABILITATION OF PATIENTS WITH CONGENITAL MALFORMATIONS ASSOCIATED WITH THALIDOMIDE - PROSTHETIC ASPECTS | 3 | 3 |
835 | 0 | 5 | 215 1963 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES 257(21):3138-& CHAMPYHATEM S SPECTROSCOPIE MOLECULAIRE - SUR LABSORPTION ULTRAVIOLETTE DU PHTALIMIDE ET DE LA THALIDOMIDE EN MILIEU ALCALIN | 3 | 6 |
836 | 0 | 0 | 218 1963 FEDERATION PROCEEDINGS 22(2):666-& DIPAOLO JA THALIDOMIDE - INFLUENCE ON PRODUCTION OF CONGENITAL ABNORMALITIES IN MICE AND CANCER CHEMOTHERAPY | 3 | 4 |
837 | 21 | 57 | 219 1963 HIROSHIMA JOURNAL OF MEDICAL SCIENCES 12(1):11-& TABUCHI A; SAWASAKI M; UMISA H; SHIRASUN.K; HORIKAWA M; YAMADA A; SHINTANI T PHOCOMELIA-LIKE DEFORMITY AND THALIDOMIDE PREPARATIONS | 3 | 3 |
838 | 0 | 7 | 247 1963 NATURE 198(488):1068-& BONEY AD ABNORMAL GROWTH OF SPORELINGS OF A MARINE RED ALGA INDUCED BY THALIDOMIDE | 3 | 10 |
839 | 11 | 15 | 257 1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 113(3):619-& SHORB MS; POLLARD W; VASAITIS V; LUND PG; SMITH C EFFECT OF THALIDOMIDE TREATMENT OF HENS ON EMBRYONIC DEVELOPMENT AND FERTILITY | 3 | 7 |
840 | 2 | 7 | 270 1964 ANATOMICAL RECORD 149(3):359-& MARINPADILLA M THALIDOMIDE INJURY TO IMPLANTED ARMADILLO BLASTOCYST | 3 | 6 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
841 | 1 | 8 | 324 1965 CANADIAN MEDICAL ASSOCIATION JOURNAL 92(6):283-& HAGEN EO CONGENITAL MALFORMATIONS IN A THALIDOMIDE BABY - A POSTMORTEM ANATOMICAL STUDY | 3 | 4 |
842 | 0 | 1 | 357 1965 TOXICOLOGY AND APPLIED PHARMACOLOGY 7(3):481-& DELAHUNT CS; KISS N; FELDMAN E; OAKES M SOME COMPARATIVE PHARMACOLOGICAL STUDIES IN MAN AND MONKEY WITH THALIDOMIDE | 3 | 6 |
843 | 8 | 20 | 401 1966 LANCET 1(7451):1373-& CHARD T; HELLMANN K IMMUNOSUPPRESSION BY THALIDOMIDE | 3 | 3 |
844 | 2 | 5 | 421 1967 BIOCHEMICAL JOURNAL 103(1):P26-& FABRO S; HAGUE D; SMITH RL FATE OF [14C]THALIDOMIDE IN PREGNANT HAMSTER | 3 | 3 |
845 | 0 | 0 | 435 1967 JOURNAL OF DENTAL RESEARCH 46(6P1S):1201-& KELSEY FO EVENTS AFTER THALIDOMIDE | 3 | 3 |
846 | 2 | 27 | 461 1968 INTERNATIONAL DENTAL JOURNAL 18(3):631-& STAHL A CLINICAL ORTHODONTIC AND RADIOLOGICAL FINDINGS IN JAWS AND FACE OF CHILDREN WITH DYSMELIA ASSOCIATED WITH THALIDOMIDE-EMBRYOPATHY | 3 | 0 |
847 | 2 | 5 | 521 1971 EXPERIENTIA 27(4):421-& KOHLER F; OCKENFEL.H COMPENSATION OF TERATOGENIC EFFECT OF A THALIDOMIDE METABOLITE BY L-GLUTAMIC ACID | 3 | 7 |
848 | 14 | 36 | 534 1971 TERATOLOGY 4(4):409-& NUDLEMAN KL; TRAVILL AA MORPHOLOGICAL AND HISTOCHEMICAL STUDY OF THALIDOMIDE-INDUCED UPPER LIMB MALFORMATIONS IN RABBIT FETUSES | 3 | 10 |
849 | 16 | 26 | 599 1974 MONATSHEFTE FUR CHEMIE 105(1):74-79 PISCHEK G; KAISER E; KOCH H THALIDOMIDE ANALOGS .5. INVESTIGATIONS OF METABOLISM OF THALIDOMIDE-LIKE COMPOUND K-2004 | 3 | 8 |
850 | 1 | 9 | 637 1977 ACTA PAEDIATRICA SCANDINAVICA 66(6):673-675 BROOK CGD; JARVIS SN; NEWMAN CGH LINEAR GROWTH OF CHILDREN WITH LIMB DEFORMITIES FOLLOWING EXPOSURE TO THALIDOMIDE INUTERO | 3 | 3 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
851 | 2 | 13 | 649 1977 JOURNAL OF MEDICAL PRIMATOLOGY 6(5):319-324 BUTLER H EFFECT OF THALIDOMIDE ON A PROSIMIAN - GREATER GALAGO (GALAGO-CRASSICAUDATUS) | 3 | 5 |
852 | 0 | 0 | 669 1978 INTERNATIONAL JOURNAL OF DERMATOLOGY 17(1):82-84 SHESKIN J STUDY WITH NINE THALIDOMIDE DERIVATIVES IN LEPRA REACTION | 3 | 8 |
853 | 0 | 24 | 687 1978 TERATOLOGY 18(3):393-403 HENDRICKX AG; SAWYER RH DEVELOPMENTAL STAGING AND THALIDOMIDE TERATOGENICITY IN GREEN MONKEY (CERCOPITHECUS-AETHIOPS) | 3 | 16 |
854 | 0 | 0 | 700 1979 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 47(2):381-382 SHANNON EJ; MIRANDA RO; HASTINGS RC EFFECT OF THALIDOMIDE ON DENOVO ANTIBODY-SYNTHESIS | 3 | 3 |
855 | 1 | 5 | 747 1981 DERMATOLOGICA 162(2):86-90 SHESKIN J; GORODETZKY R; LOEWINGER E; WEINREB A INVIVO MEASUREMENTS OF IRON, COPPER AND ZINC IN THE SKIN OF PRURIGO NODULARIS PATIENTS TREATED WITH THALIDOMIDE | 3 | 11 |
856 | 2 | 13 | 750 1981 EUROPEAN JOURNAL OF PEDIATRICS 136(3):229-230 BURGIO GR THE THALIDOMIDE DISASTER BRIEFLY REVISITED | 3 | 4 |
857 | 3 | 8 | 770 1981 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 36(9-10):904-906 KOCHERBECKER U; KOCHER W; OCKENFELS H THALIDOMIDE-LIKE MALFORMATIONS CAUSED BY A TWEEN SURFACTANT IN MICE | 3 | 6 |
858 | 4 | 10 | 785 1982 NATURWISSENSCHAFTEN 69(4):191-192 KOCHERBECKER U; KOCHER W; OCKENFELS H TERATOGENIC ACTIVITY OF A HYDROLYTIC THALIDOMIDE METABOLITE IN MICE | 3 | 4 |
859 | 3 | 4 | 798 1983 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 110(6-7):551-552 NOUGUE J; NOUGUE M; BAZEX J; HAYEK JP; BIDOUZE H OCCURRENCE OF A GENITAL HEMORRHAGIC DURING A THALIDOMIDE TREATED PRURIGO NODULARIS | 3 | 3 |
860 | 0 | 0 | 816 1983 CLINICAL RESEARCH 31(5):A920-A920 DOLL NJ; BARNHILL RL; HASTINGS RC; SALVAGGIO JE; MILLIKAN LE THALIDOMIDE INDUCED ALTERATION OF HUMAN PERIPHERAL-BLOOD MONOCYTE ACTIVITY | 3 | 3 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
861 | 7 | 12 | 823 1983 HAUTARZT 34(4):175-178 VOLCPLATZER B; WOLFF K TREATMENT OF SUBACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS WITH THALIDOMIDE | 3 | 6 |
862 | 11 | 29 | 836 1983 TERATOLOGY 27(3):327-332 PARKHIE M; WEBB M EMBRYOTOXICITY AND TERATOGENICITY OF THALIDOMIDE IN RATS | 3 | 7 |
863 | 11 | 42 | 854 1984 JOURNAL OF ANATOMY 139(OCT):397-410 MCCREDIE J; NORTH K; DEIONGH R THALIDOMIDE DEFORMITIES AND THEIR NERVE SUPPLY | 3 | 6 |
864 | 2 | 6 | 861 1984 REVUE DU RHUMATISME 51(10):585-585 TREVES R; ARNAUD M; JACOB P; LUBEAU M; TABARAUD F; BURKI F; DESPROGESGOTTERON R DRAMATIC IMPROVEMENT IN THE ARTHRITIS OF BEHCETS-DISEASE FOLLOWING THE ADMINISTRATION OF THALIDOMIDE - A CASE-REPORT | 3 | 5 |
865 | 4 | 17 | 905 1985 PSYCHOPHARMACOLOGY 85(1):47-50 KAITIN KI EFFECTS OF THALIDOMIDE AND PENTOBARBITAL ON NEURONAL-ACTIVITY IN THE PREOPTIC AREA DURING SLEEP AND WAKEFULNESS IN THE CAT | 3 | 6 |
866 | 7 | 11 | 968 1988 FUNDAMENTAL & CLINICAL PHARMACOLOGY 2(6):493-497 DESCOTES J; TEDONE R; EVREUX JC ENHANCEMENT OF ANTIBODY-RESPONSE AND DELAYED-TYPE HYPERSENSITIVITY BY THALIDOMIDE IN MICE | 3 | 3 |
867 | 13 | 40 | 1018 1990 JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 49(6):564-581 DEIONGH RU A QUANTITATIVE ULTRASTRUCTURAL-STUDY OF MOTOR AND SENSORY LUMBOSACRAL NERVE ROOTS IN THE THALIDOMIDE-TREATED RABBIT FETUS | 3 | 3 |
868 | 0 | 0 | 1026 1990 MEDICINA CLINICA 94(16):638-639 BERNARDO P; ARRIZABALAGA J; IRIBARREN JA; GARDE C EFFECTIVENESS OF THALIDOMIDE IN NONSPECIFIC ESOPHAGEAL ULCERS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY SYNDROME | 3 | 4 |
869 | 8 | 10 | 1054 1992 ARCHIVES OF INTERNAL MEDICINE 152(5):1089-1090 BOUZA E; MUNOZ P; DIAZ MD; VICENTE T THALIDOMIDE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME | 3 | 6 |
870 | 8 | 31 | 1058 1992 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 230(2):140-149 STROMLAND K; MILLER MT REFRACTIVE EVALUATION IN THALIDOMIDE EMBRYOPATHY | 3 | 5 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
871 | 5 | 6 | 1067 1992 LANCET 339(8805):1362-1362 CARMICHAEL AJ; KNIGHT A THALIDOMIDE - A RESTRICTED ROLE | 3 | 5 |
872 | 2 | 3 | 1111 1993 PRESSE MEDICALE 22(26):1233-1233 BODOKH I; LACOUR JP; RAINERO C; CASTANET J; MICHIELS JF; ORTONNE JP EFFECTIVENESS OF THALIDOMIDE AGAINST ESOPHAGEAL ULCERATION IN HIV-INFECTION | 3 | 3 |
873 | 18 | 32 | 1121 1994 BIOGENIC AMINES 10(6):543-554 AUDIT CO THALIDOMIDE-INDUCED POLYAMINE ACYLATION - A NEW INSIGHT INTO THE ACYLATION MECHANISM | 3 | 3 |
874 | 0 | 0 | 1126 1994 BRITISH MEDICAL JOURNAL 308(6936):1061-1061 ROCHA J THALIDOMIDE GIVEN TO WOMEN IN BRAZIL | 3 | 4 |
875 | 7 | 19 | 1139 1994 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 36(4):351-356 STROMLAND K; NORDIN V; MILLER M; AKERSTROM B; GILLBERG C AUTISM IN THALIDOMIDE EMBRYOPATHY - A POPULATION STUDY | 3 | 71 |
876 | 11 | 20 | 1147 1994 JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2 (9):2063-2067 REEPMEYER JC; RHODES MO; COX DC; SILVERTON JV CHARACTERIZATION AND CRYSTAL-STRUCTURE OF 2 POLYMORPHIC FORMS OF RACEMIC THALIDOMIDE | 3 | 4 |
877 | 7 | 45 | 1153 1994 LIFE SCIENCES 56(6):407-420 NEUBERT R; HELGE H; NEUBERT D THALIDOMIDE AND THE IMMUNE-SYSTEM .4. DOWN-REGULATION OF THE CD26 RECEPTOR, PROBABLY INVOLVED IN THE BINDING OF HIV COMPONENTS TO T-CELLS IN PRIMATES | 3 | 4 |
878 | 0 | 0 | 1156 1994 PANMINERVA MEDICA 36(1):1-4 VOSGERAU JCB AUTOIMMUNITY IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE USE OF THALIDOMIDE | 3 | 3 |
879 | 0 | 8 | 1167 1995 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 122(9):609-611 Safa G; Joly P; Boullie MC; Thomine E; Lauret P Treatment of 2 cases of Melkersson-Rosenthal syndrome with thalidomide | 3 | 8 |
880 | 4 | 22 | 1170 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 39(12):2807-2809 PETERSON PK; GEKKER G; BORNEMANN M; CHATTERJEE D; CHAO CC THALIDOMIDE INHIBITS LIPOARABINOMANNAN-INDUCED UP-REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION | 3 | 10 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
881 | 18 | 38 | 1210 1995 LIFE SCIENCES 58(4):295-316 Neubert R; Hinz N; Thiel R; Neubert D Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide | 3 | 7 |
882 | 0 | 0 | 1217 1995 NATURE MEDICINE 1(12):1230-1230 GERSHON D FINDING NEW USES FOR THALIDOMIDE | 3 | 5 |
883 | 11 | 16 | 1231 1996 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 53(4):429-431 Minor JR; Piscitelli SC Thalidomide in diseases associated with human immunodeficiency virus infection | 3 | 4 |
884 | 10 | 22 | 1240 1996 ARCHIVES OF TOXICOLOGY 70(11):749-756 Schmahl HJ; Dencker L; Plum C; Chahoud I; Nau H Stereoselective distribution of the teratogenic thalidomide analogue EM12 in the early embryo of marmoset monkey, Wistar rat and NMRI mouse | 3 | 7 |
885 | 24 | 33 | 1285 1996 LUPUS 5(4):257-258 Stevens RJ The place of thalidomide in the treatment of inflammatory disease | 3 | 5 |
886 | 19 | 42 | 1329 1997 CLINICAL NEUROPHARMACOLOGY 20(2):152-164 Zhu J; Bai XF; Mix E; vanderMeide PH; Zwingenberger K; Link H Thalidomide suppresses T-and B-cell responses to myelin antigen in experimental allergic neuritis | 3 | 4 |
887 | 2 | 5 | 1373 1997 NATURE 389(6647):118-118 Ashby J Thalidomide is not a mutagen | 3 | 4 |
888 | 7 | 11 | 1389 1997 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 17(1):R1-R2 Neubert D Never-ending tales of the mode of the teratogenic action of thalidomide | 3 | 5 |
889 | 9 | 10 | 1426 1998 CLINICAL AND EXPERIMENTAL DERMATOLOGY 23(3):141-141 Georgala S; Katoulis AC; Hasapi V; Koumantaki-Mathioudaki E Thalidomide treatment for hypertrophic lupus erythematosus | 3 | 3 |
890 | 12 | 15 | 1449 1998 JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES 21(14):2151-2163 Haque A; Stewart JT Determination of racemic thalidomide in human plasma by use of an avidin column and solid phase extraction | 3 | 5 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
891 | 3 | 5 | 1476 1998 REVUE DE MEDECINE INTERNE 19(3):208-209 Grasland A; Pouchot J; Chaumaiziere D; Aitken G; Vinceneux P Effectiveness of thalidomide in cutaneous sarcoidosis | 3 | 4 |
892 | 13 | 16 | 1525 1999 CLEVELAND CLINIC JOURNAL OF MEDICINE 66(3):136-+ Calabrese LH Thalidomide's tightly controlled "comeback" | 3 | 3 |
893 | 12 | 70 | 1536 1999 DRUGS 58(6):953-963 Ravot E; Lisziewicz J; Lori F New uses for old drugs in HIV infection - The role of hydroxyurea, cyclosporin and thalidomide | 3 | 15 |
894 | 0 | 0 | 1541 1999 GASTROENTEROLOGY 116(4):A837-A837 Vasiliauskas EA; Kam LY; Abreu-Martin MT; Papadakis KA; Zeldis JB; Targan SR An open-label, stepwise dose-escalating pilot study to evaluate the safety, tolerance, & efficacy of low-dose thalidomide in the treatment of chronically-active, steroid-department Crohn's disease (CD) | 3 | 0 |
895 | 3 | 10 | 1578 1999 LUPUS 8(3):248-249 Rua-Figueroa I; Erausquin C; Naranjo A; Carretero-Hernandez G; Rodriguez-Lozano C; De la Rosa P Pustuloderma during cutaneous lupus treatment with thalidomide | 3 | 5 |
896 | 30 | 79 | 1581 1999 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 425(1):153-167 Zhu XY; Zhang YP; Klopman G; Rosenkranz HS Thalidomide and metabolites: indications of the absence of 'genotoxic' carcinogenic potentials | 3 | 3 |
897 | 4 | 11 | 1582 1999 NATURE 400(6743):419-420 Neubert R; Merker HT; Neubert D Developmental model for thalidomide action | 3 | 4 |
898 | 19 | 39 | 1591 1999 ORGANIC LETTERS 1(10):1571-1573 Takeuchi Y; Shiragami T; Kimura K; Suzuki E; Shibata N (R)- and (S)-3-fluorothalidomides: Isosteric analogues of thalidomide | 3 | 13 |
899 | 5 | 8 | 1596 1999 PHARMACOLOGY & TOXICOLOGY 85(2):103-104 Huang PHT; McBride WG; Tuman WG Interaction of thalidomide with DNA of rabbit embryos: A possible explanation for its immunosuppressant and teratogenic effects | 3 | 3 |
900 | 14 | 17 | 1599 1999 REVUE DE MEDECINE INTERNE 20(7):567-570 de Wazieres B; Gil H; Magy N; Berthier S; Vuitton DA; Dupond JL Treatment of recurrent oro-genital ulceration with low dose of thalidomide. Pilot study in 17 patients | 3 | 8 |
Page 3: 1 2 3 4 5 6 7 8 9
Generated by:
HistCite(Vlad).
Version: 2004.09.22